genital%20herpes
GENITAL HERPES
Genital herpes is a recurrent lifelong disease with no cure, caused by herpes simplex virus (HSV).
HSV-2 is usually the cause but HSV-1 may occur in up to 1/3 of new cases.
HSV-1 tends to cause fewer recurrences & milder disease than HSV-2.
The incubation period is 2 days-2 weeks after exposure.
Drug Information

Indication: Treatment & prevention of herpes simplex virus infections, genital herpes of the skin & mucous membran...

Indication: HSV skin infections including initial & recurrent genital herpes labialis.

Indication: Herpes simplex virus infections of the skin & mucous membranes including initial & recurrent genital h...

Indication: Herpes simplex virus skin infection including genital herpes & herpes labialis.

Indication: Herpes zoster. Accelerates the resolution of pain by reducing the duration & proportion of patients w/ zos...

Indication: Promoting resolution of acute clinical manifestations of mucocutaneous Herpes simplex virus infections in immu...

Indication: Herpes simplex skin infections including initial & recurrent labial & genital herpes simplex infection...

Dosage: Adult Herpes simplex infections 200 mg 5 times daily at 4-hrly intervals for 5 days. Severely immunocompromise

Indication: Treatment & prophylaxis of herpes genitalis, treatment of herpes zoster, herpes simples & varicella (chickenpo...

Indication: Herpes simplex infections in immunocompromised patients & severe initial genital herpes in the non-immunoc...

1  /  4
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Infectious Diseases - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
01 Aug 2014

Extracted from the speech by UNAIDS Executive Director Michel Sidibé at the opening session of the 20th International AIDS Conference (AIDS 2014) held in Melbourne, Australia.

Pearl Toh, 03 Nov 2017
Increasing daily water intake by 1.5 L can half the risk of recurrent acute uncomplicated cystitis (rAUC) in women, suggests a study presented at the recent Infectious Disease Week (IDWeek) in San Diego, California, US.
24 Dec 2015
Imipenem-cilastatin exhibited better efficacy than piperacillin-tazobactam as empiric antibiotic for febrile neutropaenia in haematopoietic stem cell transplantation (HSCT) recipients, based on a study.